Visceral leishmaniasis: An overview of vaccine adjuvants and their applications-Reference-Cited by-同舟云学术

Visceral leishmaniasis: An overview of vaccine adjuvants and their applications

Published:2019-06 Issue:27 Volume:37 Page:3505-3519
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ratnapriya Sneha,Keerti ,Sahasrabuddhe Amogh A.,Dube Anuradha^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference154 articles.

1. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?;Chappuis;Nat Rev Microbiol,2007

2. Relapse of visceral leishmaniasis in an HIV-infected patient successfully treated with a combination of miltefosine and amphotericin B;McQuarrie;Can J Infect Dis Med Microbiol,2015

3. decline in clinical efficacy of oral miltefosine in treatment of post kala-azar dermal leishmaniasis (PKDL) in India;Ramesh;PLoS Negl Trop Dis,2015

4. Drug susceptibility in Leishmania isolates following Miltefosine treatment in cases of Visceral Leishmaniasis and post Kala-Azar dermal Leishmaniasis;Bhandari;PLoS Negl Trop Dis,2012

5. Adjuvants for Leishmania vaccines: from models to clinical application;Raman;Front Immunol,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Killed Vaccine Candidate with Different Adjuvants to Determine Prophylactic Potential against Leishmaniasis;Acta Parasitologica;2024-08-20

2. Hydroxyapatite as Nanoparticle-based Adjuvant: Leishmaniasis Vaccine Candidate;Current Analytical Chemistry;2024-05-21

3. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

4. Immunogenicity and protective efficacy of tuzin protein as a vaccine candidate in Leishmania donovani-infected BALB/c mice;Frontiers in Immunology;2024-01-11

5. Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines;Cancer Research;2023-12-06